Rachel Rennard

712 citations
18 papers · 511 · h-index 12

Impact in

Papers in

  • Molecular Biology 11
    • Glycosylation and Glycoproteins Research 6
    • RNA and protein synthesis mechanisms 3
    • RNA Research and Splicing 2
  • Oncology 6
    • HER2/EGFR in Cancer Research 4
    • Peptidase Inhibition and Analysis 2
Co-authors
Alan M. Lambowitz (3 shared papers)Thomas J. Sferra (2 shared papers)Neeraj Kohli (7 shared papers)Yang Jiao (6 shared papers)Georg Mohr (2 shared papers)Alexey A. Lugovskoy (6 shared papers)Lihui Xu (6 shared papers)Paul D. Rennert (2 shared papers)
Journals
mAbs (3 papers)The Journal of Immunology (2 papers)Cancer Research (2 papers)Molecular Cancer Therapeutics (2 papers)Journal of Molecular Biology (2 papers)
Partner nations
United States

In The Last Decade

Rachel Rennard

18 papers receiving 499 citations

Peers

Rachel Rennard
Comparison fields: 5 of 68
  • Immunology 126
  • Radiology, Nuclear Medicine and Imaging 108
  • Oncology 121
  • Molecular Biology 271
  • Genetics 32
Replace Thomas Grussenmeyer with:
Thomas Grussenmeyer Germany
Fabian Richter Germany
Mi Sook Chang United States
Lucio Gómez Spain
Claude Tschopp Switzerland
Karen E. Strunk United States
Alexander J. Finn United States
Jonathan Skupsky United States
Lourdes Places Spain
Hongkang Xi United States
Rachel Rennard relative to Thomas Grussenmeyer Germany Thomas Grussenmeyer's profile →
Citations per field
00.5×1.5×2.1×
Thomas Grussenmeyer · 1×
Citations per year

Countries citing papers authored by Rachel Rennard

Since Specialization
Citations

This map shows the geographic impact of Rachel Rennard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Rennard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Rennard more than expected).

Fields of papers citing papers by Rachel Rennard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Rennard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Rennard. The network helps show where Rachel Rennard may publish in the future.

Co-authors

The 25 scholars most cited alongside Rachel Rennard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rachel Rennard Line = papers co-authored together Rachel Rennard links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1
MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors
Molecular Cancer Therapeutics ·Jonathan B. Fitzgerald, Bryan W. Johnson, Jason Baum, Sharlene Adams, Sergio Iadevaia, Jian Tang, Victoria Rimkunas, Lihui Xu, Neeraj Kohli, Rachel Rennard, Maja Razlog, Yang Jiao, Brian D. Harms, Kenneth J. Olivier, Birgit Schoeberl, Ulrik B. Nielsen, Alexey A. Lugovskoy
201386
2
Epitope-Dependent Effect of Anti-Murine TIM-1 Monoclonal Antibodies on T Cell Activity and Lung Immune Responses
The Journal of Immunology ·Irene Sizing, Véronique Bailly, Patricia McCoon, Wenjie Chang, Sambasiva P. Rao, Lourdes Pablo, Rachel Rennard, Meghan E. Walsh, Zhifang Li, Mohammad Zafari, Max Dobles, Leticia Tarilonte, Steven D. Miklasz, Gerard R. Majeau, Kevin Godbout, Martin Scott, Paul D. Rennert
200766
3
T Cell, Ig Domain, Mucin Domain-2 Gene-Deficient Mice Reveal a Novel Mechanism for the Regulation of Th2 Immune Responses and Airway Inflammation
The Journal of Immunology ·Paul D. Rennert, Takaharu Ichimura, Irene Sizing, Véronique Bailly, Zhifang Li, Rachel Rennard, Patricia McCoon, Lourdes Pablo, Steven D. Miklasz, Leticia Tarilonte, Joseph V. Bonventre
200664
4
Recombinant Adeno-Associated Virus-Mediated Correction of Lysosomal Storage within the Central Nervous System of the Adult Mucopolysaccharidosis Type VII Mouse
Human Gene Therapy ·Thomas J. Sferra, Guang Qu, David L. McNeely, Rachel Rennard, K. Reed Clark, Warren Lo, Philip R. Johnson
200055
5
Widespread Correction of Lysosomal Storage Following Intrahepatic Injection of a Recombinant Adeno-associated Virus in the Adult MPS VII Mouse
Molecular Therapy ·Thomas J. Sferra, Kristin C. Backstrom, Chuansong Wang, Rachel Rennard, M.T. Miller, Yanmin Hu
200444
6
Function of the Neurospora crassa mitochondrial tyrosyl-tRNA synthetase in RNA splicing. Role of the idiosyncratic N-terminal extension and different modes of interaction with different group I introns
Journal of Molecular Biology ·Georg Mohr, Rachel Rennard, Andrew D. Cherniack, John M. Stryker, Alan M. Lambowitz
200137
7
Characterization of Neurospora mitochondrial group I introns reveals different CYT-18 dependent and independent splicing strategies and an alternative 3' splice site for an intron ORF.
PubMed ·Gerald Wallweber, Sabine Mohr, Rachel Rennard, Mark G. Caprara, Alan M. Lambowitz
199729
8
Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle
mAbs ·Kathy Zhang, Melissa L. Geddie, Neeraj Kohli, Tad Kornaga, Dmitri B. Kirpotin, Yang Jiao, Rachel Rennard, Daryl C. Drummond, Ulrik B. Nielsen, Lihui Xu, Alexey A. Lugovskoy
201427
9
A Tyrosyl-tRNA Synthetase Suppresses Structural Defects in the Two Major Helical Domains of the Group I Intron Catalytic Core
Journal of Molecular Biology ·Christopher A. Myers, Gerald Wallweber, Rachel Rennard, Yelena Kemel, Mark G. Caprara, Georg Mohr, Alan M. Lambowitz
199627
10
Improving the developability of an anti-EphA2 single-chain variable fragment for nanoparticle targeting
mAbs ·Melissa L. Geddie, Neeraj Kohli, Dmitri B. Kirpotin, Maja Razlog, Yang Jiao, Tad Kornaga, Rachel Rennard, Lihui Xu, Birgit Schoerberl, James D. Marks, Daryl C. Drummond, Alexey A. Lugovskoy
201623
11
Rapid optimization and prototyping for therapeutic antibody-like molecules
mAbs ·Lihui Xu, Neeraj Kohli, Rachel Rennard, Yang Jiao, Maja Razlog, Kathy Zhang, Jason Baum, Bryan W. Johnson, Jian Tang, Birgit Schoeberl, Jonathan B. Fitzgerald, Ulrik B. Nielsen, Alexey A. Lugovskoy
201321
12
Cell cycle regulation of polymorphism in Wangiella dermatitidis.
PubMed ·Paul J. Szaniszlo, Sankunny Mohan Karuppayil, (unknown), Rachel Rennard
199312
13
ANGPTL7 and Its Role in IOP and Glaucoma
Investigative Ophthalmology & Visual Science ·Suzette Farber-Katz Brown, Hien Thi Thu Nguyen, Philip Mzyk, Michael L. De Ieso, Andrea M. Unser, Ian E. Brown, Pujhitha Ramesh, Hira Afzaal, Feryan Ahmed, Karen Y. Torrejon, Alan Nhan, Dalton Markrush, Tom Daly, Ellie Knecht, William McConaughy, Sara Halmos, Zhiquan Lucy Liu, Rachel Rennard, A. Brooke Peterson, W. Daniel Stamer
20247
14
Antibodies directed to α6β4 highlight the adhesive and signaling functions of the integrin in breast cancer cell lines
Cancer Biology & Therapy ·Veronica Gabarra, Samuel K. Cho, Miriam Ramírez, Yan Ren, Ling Ling Chen, Anne E. Cheung, Xianjun Cao, Rachel Rennard, Kelsey R. Unruh, Christilyn Graff, Beth Browning, Heather Huet, Karen R. McLachlan
20105
15
Abstract 2719: MM-141, a novel bispecific antibody co-targeting IGF-1R and ErbB3, blocks ligand-induced signaling and demonstrates antitumor activity
Cancer Research ·Jason Baum, Bryan W. Johnson, Sharlene Adams, Jian Tang, Neeraj Kohli, Rachel Rennard, Pragalath Sundararajan, Lihui Xu, Yang Jiao, Birgit Schoeberl, Ulrik B. Nielsen, Jonathan B. Fitzgerald, Alexey A. Lugovskoy
20123
16
Abstract 3239: CTX-5861 mediated SIRPα blockade combines with tumor targeting antibodies, checkpoint blockade and/or CD137 agonism to elicit curative anti-tumor activity in syngeneic mouse models
Cancer Research ·Uğur Eskiocak, Wilson Guzman, Thomas J. Daly, Allison Nelson, Pearl Bakhru, Jason Lajoie, Sara M. Haserlat, Samantha Ottinger, Lucy Liu, Amanda Oliphant, Alan Leung, Girish Hemashettar, Rachel Rennard, Benjamin Wolf, Monia Draghi, Michael M. Schmidt, Robert M. Tighe
20192
17
Abstract B205: Therapeutically targeting redundant, growth factor-induced prosurvival signaling with MM-141, a novel bispecific antibody targeting IGF-1R and ErbB3.
Molecular Cancer Therapeutics ·Alexey A. Lugovskoy, Bryan W. Johnson, Jason Baum, Sharlene Adams, Jian Tang, Neeraj Kohli, Rachel Rennard, Lihui Xu, Yang Jiao, Ulrik Nilesen, Jonathan B. Fitzgerald
20112
18
A cartilage-targeted insulin-like growth factor-1 is retained in cartilage and promotes extracellular matrix maintenance in rat medial meniscus tear model
Osteoarthritis and Cartilage ·Emily Florine, Paul W. Kopesky, Rachel Rennard, Neeraj Kohli, J. Kim, Susan Chubinskaya, A.M. Bendele, Alan J. Grodzinsky, Birgit Schoeberl
20171

About Rachel Rennard

Rachel Rennard is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Immunology and Physiology, having authored 18 papers that have together received 511 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (4 papers), RNA and protein synthesis mechanisms (3 papers), Galectins and Cancer Biology (2 papers), Adenosine and Purinergic Signaling (2 papers), RNA Research and Splicing (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Immunology (126 citations), Radiology, Nuclear Medicine and Imaging (108 citations), Oncology (121 citations), Molecular Biology (271 citations) and Genetics (32 citations). Rachel Rennard has collaborated with scholars based in United States. Frequent co-authors include Alan M. Lambowitz, Thomas J. Sferra, Neeraj Kohli, Yang Jiao, Georg Mohr, Alexey A. Lugovskoy, Lihui Xu, Paul D. Rennert, Gerald Wallweber and Patricia McCoon. Their work appears in journals such as mAbs, The Journal of Immunology, Cancer Research, Molecular Cancer Therapeutics and Journal of Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas GrussenmeyerBreakdown of academic impact, for papers by Fabian RichterBreakdown of academic impact, for papers by Mi Sook ChangBreakdown of academic impact, for papers by Lucio GómezBreakdown of academic impact, for papers by Claude TschoppBreakdown of academic impact, for papers by Karen E. StrunkBreakdown of academic impact, for papers by Alexander J. FinnBreakdown of academic impact, for papers by Jonathan SkupskyBreakdown of academic impact, for papers by Lourdes PlacesBreakdown of academic impact, for papers by Hongkang Xi